On October 16, Bath & Body Works Inc. rose 8.26% in Regular Trading, trading at $20.5 per share, with turnover of $116 million.
The move followed stronger-than-expected quarterly results and improved full-year guidance. The company reported second-quarter adjusted EPS of $0.62, well above the $0.24 consensus estimate, on revenue of $1.514 billion versus expectations of $1.497 billion.
Bath & Body Works Inc. also narrowed its full-year sales outlook to a decline of 4% to 2.5%, raised adjusted EPS guidance to $2.60 to $2.80 from $2.40 to $2.65, and projected about $650 million in free cash flow. The updated outlook indicated improving execution in its transformation efforts and helped reinforce investor confidence.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments